- Home
- ASTC vs RDHL Comparison
ASTC vs RDHL Comparison
Compare ASTC & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ASTC | RDHL |
|---|---|---|
| Founded | 1984 | 2009 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9M | 5.6M |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | ASTC | RDHL |
|---|---|---|
| Price | $3.55 | $1.03 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 138.0K | 71.5K |
| Earning Date | 02-13-2026 | 09-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $1,312,000.00 | ★ $9,550,000.00 |
| Revenue This Year | N/A | $381.91 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 3.06 | ★ 157.62 |
| 52 Week Low | $2.47 | $0.91 |
| 52 Week High | $8.01 | $6.80 |
Technical Indicators
Market Signals| Indicator | ASTC | RDHL |
|---|---|---|
| Relative Strength Index (RSI) | 47.71 | 38.43 |
| Support Level | $3.31 | $0.91 |
| Resistance Level | $3.88 | $1.23 |
| Average True Range (ATR) | 0.37 | 0.07 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 29.75 | 46.21 |
Price Performance
Historical ComparisonAbout ASTC Astrotech Corporation (DE)
Astrotech Corp is a science and technology development company. The firm invents, acquires, and commercializes technological innovations sourced from internal research, universities, laboratories, and research institutions. The 1st Detect develops, manufactures, and sells chemical analyzers for use in the airport security, military, and breath analysis markets. AgLAB develops a series of mass spectrometers for use in the agriculture market.
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.